Peak Bio, Inc. Proceeds from Notes Payable
Peak Bio, Inc. reported Proceeds from Notes Payable of $1.24 million for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-07-12.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2023-07-12
- Peak Bio, Inc. proceeds from notes payable for the quarter ending 2023-03-31 was $1.24M.
- Peak Bio, Inc. proceeds from notes payable for the quarter ending 2022-03-31 was $0.00.
| Period end | Proceeds from Notes Payable 3 month |
|---|---|
| 2023-03-31 | $1.24M 10-Q · filed 2023-07-12 |
| 2022-03-31 | $0.00 10-Q · filed 2023-07-12 |